ATE495752T1 - Verfahren und zusammensetzungen zur notfallbedingten verhütung mithilfe von endothelin-rezeptor-antagonisten - Google Patents

Verfahren und zusammensetzungen zur notfallbedingten verhütung mithilfe von endothelin-rezeptor-antagonisten

Info

Publication number
ATE495752T1
ATE495752T1 AT06787856T AT06787856T ATE495752T1 AT E495752 T1 ATE495752 T1 AT E495752T1 AT 06787856 T AT06787856 T AT 06787856T AT 06787856 T AT06787856 T AT 06787856T AT E495752 T1 ATE495752 T1 AT E495752T1
Authority
AT
Austria
Prior art keywords
receptor antagonists
compositions
endothelin receptor
emergency contraception
contraception
Prior art date
Application number
AT06787856T
Other languages
English (en)
Inventor
Indrani Bagchi
Regine Sitruk-Ware
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of ATE495752T1 publication Critical patent/ATE495752T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2285—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT06787856T 2005-07-19 2006-07-19 Verfahren und zusammensetzungen zur notfallbedingten verhütung mithilfe von endothelin-rezeptor-antagonisten ATE495752T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70045505P 2005-07-19 2005-07-19
PCT/US2006/028031 WO2007012006A1 (en) 2005-07-19 2006-07-19 Methods and compositions for emergency contraception using endothelin receptor antagonists

Publications (1)

Publication Number Publication Date
ATE495752T1 true ATE495752T1 (de) 2011-02-15

Family

ID=37669144

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06787856T ATE495752T1 (de) 2005-07-19 2006-07-19 Verfahren und zusammensetzungen zur notfallbedingten verhütung mithilfe von endothelin-rezeptor-antagonisten

Country Status (8)

Country Link
US (1) US8173593B2 (de)
EP (2) EP2246062B1 (de)
AT (1) ATE495752T1 (de)
CA (1) CA2615393C (de)
DE (1) DE602006019733D1 (de)
ES (2) ES2359513T3 (de)
MX (1) MX2008000874A (de)
WO (1) WO2007012006A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) * 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL74665C (de) 1949-04-07
US2863846A (en) 1950-05-04 1958-12-09 Dow Corning Organo silyl-silica filled siloxane elastomers and process for producing same
US2890188A (en) 1951-12-17 1959-06-09 Dow Corning Siloxane elastomers compounded with hydroxylated silanes
NL91756C (de) 1953-11-19
GB804199A (en) 1955-12-22 1958-11-12 Midland Silicones Ltd Organosiloxane compositions
GB798669A (en) 1956-12-12 1958-07-23 Midland Silicones Ltd Improvements in or relating to organosiloxane elastomer foams
US2927907A (en) 1957-01-07 1960-03-08 Dow Corning Siloxane elastomers
US3022951A (en) 1957-05-14 1962-02-27 Ibm Full adder
US3035016A (en) 1959-03-16 1962-05-15 Dow Corning Acyloxy siloxanes and a method of using the
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3920805A (en) 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
US4155991A (en) 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
IL48277A (en) 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US3995633A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US3995634A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US3991760A (en) 1975-12-02 1976-11-16 The Procter & Gamble Company Vaginal medicament dispensing means
US4310510A (en) 1976-12-27 1982-01-12 Sherman Kenneth N Self administrable anti-fertility composition
US4286587A (en) 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4250611A (en) 1979-04-19 1981-02-17 Alza Corporation Process for making drug delivery device with reservoir
US4368186A (en) 1981-05-07 1983-01-11 Syntex (U.S.A.) Inc. Methods and compositions for intravaginal contraception
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
EP0180264A1 (de) 1984-10-12 1986-05-07 Akzo N.V. Entladungssysteme für zwei oder mehrere aktive Substanzen
US4585647A (en) 1984-11-19 1986-04-29 Basf Corporation Methods and compositions for intravaginal contraception
NL8500470A (nl) 1985-02-19 1986-09-16 Achel Homesteel Pvba Intravaginaal orgaan.
ES2029831T3 (es) 1986-03-12 1992-10-01 Euroceltique Sa Un procedimiento para la preparacion de una composicion contraceptiva para aplicacion a la vagina de un mamifero hembra.
US5284828A (en) 1990-05-14 1994-02-08 Fujisawa Pharmaceutical Co. Ltd. Peptide compound and its preparation
US5382569A (en) 1991-05-16 1995-01-17 Warner-Lambert Company Endotherlin antagonists
US5378715A (en) 1992-02-24 1995-01-03 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
US5550110A (en) 1992-04-22 1996-08-27 Warner-Lambert Company Endothelin Antagonists II
FI95768C (fi) 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
ZA947572B (en) 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
US5811416A (en) * 1994-06-06 1998-09-22 Board Of Regents The University Of Texas System Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate
US6162927A (en) 1994-08-19 2000-12-19 Abbott Laboratories Endothelin antagonists
US5766681A (en) 1995-06-22 1998-06-16 Styro-Stop, Inc. Insulation barrier and a method of making an insulation barrier
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US6207696B1 (en) 1998-09-15 2001-03-27 Cytos Pharamaceuticals, Llc Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine
US6545048B1 (en) 1999-06-29 2003-04-08 California Institute Of Technology Compositions and methods of treating cancer using compositions comprising an inhibitor or endothelin receptor activity
WO2003093322A2 (en) 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
US20040138121A1 (en) * 2002-10-24 2004-07-15 Anil Gulati Method and composition for preventing and treating solid tumors

Also Published As

Publication number Publication date
US8173593B2 (en) 2012-05-08
ES2395922T3 (es) 2013-02-18
EP1906987B1 (de) 2011-01-19
ES2359513T3 (es) 2011-05-24
WO2007012006A1 (en) 2007-01-25
EP1906987A4 (de) 2009-01-28
CA2615393C (en) 2011-09-20
EP1906987A1 (de) 2008-04-09
CA2615393A1 (en) 2007-01-25
DE602006019733D1 (de) 2011-03-03
EP2246062B1 (de) 2012-09-26
EP2246062A1 (de) 2010-11-03
MX2008000874A (es) 2008-04-04
US20090203591A1 (en) 2009-08-13

Similar Documents

Publication Publication Date Title
DE602007010420D1 (de) Verfahren zur verwendung des gpr119-rezeptors zur identifizierung von verbindungen zur erhöhung der knochenmasse bei einer person
DE602004018714D1 (de) Verfahren zur Bereitstellung von zweiteiligen, selbstklebenden Dentalmassen
DE602006002541D1 (de) Kommunikationsgerät, Kommunikationssystem, und Verfahren zur Einstellung von Kommunikationsparametern des Kommunikationsgeräts
ATE461925T1 (de) Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung
UA95768C2 (ru) Антагонисты мускариновых рецепторов ацетилхолина
DE502005002345D1 (de) Verfahren zur einstellung von sitzkomponenten
EP1799260A4 (de) Antiamyloide antikörper, zusammensetzungen, verfahren und verwendungen
DE602006021318D1 (de) Insektizidzusammensetzungen und verfahren zur hersn
EP2051660A4 (de) Vorrichtung und verfahren zur einsetzung von implantaten
DE602006009444D1 (de) Vorrichtungen und Verfahren zur Regelung von stroboskopischer Beleuchtung
ATE524944T1 (de) Verfahren und vorrichtung zur übermittlung von rückstandsinformationen
EP1833992A4 (de) Pcv2-immunogene zusammensetzungen und verfahren zur herstellung solcher zusammensetzungen
DE602006004529D1 (de) Verfahren und Vorrichtung zur Kontrolle von Objekten
DE602006015182D1 (de) Zusammensetzung und verfahren zur kontrolle von insekten
DE602005024986D1 (de) Verfahren und vorrichtung zur generatorsteuerung
DE502005008502D1 (de) Vorrichtung zur veränderung der steuerzeiten von g
DE602006008098D1 (de) Verfahren und System zur Verwaltung von Datenverkehr
DE602005018856D1 (de) Verfahren und Vorrichtung zur Übertragung von Verkehrsinformationen
DE602005023337D1 (de) Verfahren und vorrichtung zur formteilinstallation
DE602006008934D1 (de) Neue aminogruppentransferase, dafür codierendes gen und verfahren zur verwendung davon
ATE549416T1 (de) Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten
DE602006005208D1 (de) Tonerzusammensetzung und Verfahren
ATE495752T1 (de) Verfahren und zusammensetzungen zur notfallbedingten verhütung mithilfe von endothelin-rezeptor-antagonisten
DE602006010400D1 (de) Olanzapin-analoga und verfahren zu ihrer verwendung
DE602006015265D1 (de) System und Verfahren zur Aufzugsgruppensteuerung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties